Synphilin-1 transgenic mice exhibit mild motor impairments

Neuroscience Letters

Volumn 445, Issue 1, 2008, Pages 12-17

  Jin, Hong Guo ^a,b   Yamashita, Hiroshi ^a   Nakamura, Takeshi ^a   Fukuba, Hiromasa ^a   Takahashi, Tetsuya ^a   Hiji, Masanori ^a   Kohriyama, Tatsuo ^a   Matsumoto, Masayasu ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b People's Hospital of Zhoushan City   (China)

Author keywords

Synuclein; Parkinson's disease; Synphilin 1; Transgenic mice; Tyrosine hydroxylase

Indexed keywords

CYTOPLASM PROTEIN; SYNPHILIN 1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UBIQUITINATION;

ALPHA-SYNUCLEIN; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CARRIER PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; MOVEMENT DISORDERS; NERVE TISSUE PROTEINS; NEURONS; REACTION TIME; TYROSINE 3-MONOOXYGENASE;

EID: 52949139399     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.08.073     Document Type: Article

References (16)

1. Abel A., Walcott J., Woods J., Duda J., and Merry D.E. Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. Hum. Mol. Genet. 10 (2001) 107-116
2. Von Coelln R., Thomas B., Savitt J.M., Lim K.L., Sasaki M., Hess E.J., Dawson V.L., and Dawson T.M. Loss of locus coeruleus neurons and reduced startle in Parkin null mice. Proc. Natl. Acad. Sci. USA 101 (2004) 10744-10749
3. Engelender S., Kaminsky Z., Guo X., Sharp A.H., Amaravi R.K., Kleiderlein J.J., Margolis R.L., Troncoso J.C., Lanahan A.A., Worley P.F., Dawson V.L., Dawson T.M., and Ross C.A. Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions. Nat. Genet. 22 (1999) 110-114
4. Eyal A., Szargel R., Avraham E., Liani E., Haskin J., Rott R., and Engelender S. Synphilin-1A: an aggregationprone isoform of synphilin-1 that causes neuronal death and is present in aggregates from α-synucleinopathy patients. Proc. Natl. Acad. Sci. USA 103 (2006) 5917-5922
5. Fleming S.M., Salcedo J., Fernagut P.O., Rockenstein E., Masliah E., Levine M.S., and Chesselet M.F. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human α-synuclein. J. Neurosci. 24 (2004) 9434-9440
6. Fukuba H., Takahashi T., Jin H.G., Kohriyama T., and Matsumoto M. Abundance of aspargynyl-hydroxylase FIH is regulated by Siah-1 under normoxic conditions. Neurosci. Lett. 433 (2008) 209-214
7. Goldberg M.S., Fleming S.M., Palacino J.J., Cepeda C., Lam H.A., Bhatnagar A., Meloni E.G., Wu N., Ackerson L.C., Klapstein G.J., Gajendiran M., Roth B.L., Chesselet M.F., Maidment N.T., Levine M.S., and Shen J. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. 278 (2003) 43628-43635
8. Hoshino T., Kawase Y., Okamoto M., Yokota K., Yoshino K., Yamamura K., Miyazaki J., Young H.A., and Oizumi K. Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function. J. Immunol. 166 (2001) 7014-7018
9. Liani E., Eyal A., Avraham E., Shemer R., Szargel R., Berg D., Bornemann A., Riess O., Ross C.A., Rott R., and Engelender S. Ubiquitylation of synphilin-1 and α-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease. Proc. Natl. Acad. Sci. USA 101 (2004) 5500-5505
10. Marx F.P., Soehn A.S., Berg D., Melle C., Schiesling C., Lang M., Kautzmann S., Strauss K.M., Franck T., Engelender S., Pahnke J., Dawson S., von Eggeling F., Schulz J.B., Riess O., and Kruger R. The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein-implications for Parkinson's disease. FASEB J. 21 (2007) 1759-1767
11. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., and Mucke L. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287 (2000) 1265-1269
12. Masuya H., Inoue M., Wada Y., Shimizu A., Nagano J., Kawai A., Inoue A., Kagami T., Hirayama T., Yamaga A., Kaneda H., Kobayashi K., Minowa O., Miura I., Gondo Y., Noda T., Wakana S., and Shiroishi T. Implementation of the modified-SHIRPA protocol for screening of dominant phenotypes in a large-scale ENU mutagenesis program. Mamm. Genome 16 (2005) 829-837
13. Nagano Y., Yamashita H., Takahashi T., Kishida S., Nakamura T., Iseki E., Hattori N., Mizuno Y., Kikuchi A., and Matsumoto M. Siah-1 facilitates ubiquitination and degradation of synphilin-1. J. Biol. Chem. 278 (2003) 51504-51514
14. Szargel R., Rott R., and Engelender S. Synphilin-1 isoforms in Parkinson's disease: regulation by phosphorylation and ubiquitylation. Cell Mol. Life Sci. 65 (2008) 80-88
15. Wakabayashi K., Engelender S., Yoshimoto M., Tsuji S., Ross C.A., and Takahashi H. Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann. Neurol. 47 (2000) 521-523
16. Yamashita H., and Matsumoto M. Molecular pathogenesis, experimental models, and new therapeutic strategies for Parkinson's disease. Regen. Med. 2 (2007) 447-455